Ecole Doctorale Régionale d'Infectiologie Tropicale, Franceville, Gabon.
Cabinet Médical de Gynécologie Obstétrique "La Renaissance Plus", N'Djamena, Chad.
Int J Gynaecol Obstet. 2020 May;149(2):123-129. doi: 10.1002/ijgo.13112. Epub 2020 Feb 27.
Human papillomavirus (HPV) testing may be feasible for primary cervical cancer screening in low-resource countries.
To compare self-sampling by women with clinician-performed sampling for HPV testing in Africa.
MEDLINE, Google scholar, EMBASE, and several journals were searched from 2000 until 2015 using relevant terms.
Selected studies compared self-sampled and clinician-sampled HPV tests.
Data extraction forms included description of the type of HPV screening, description of any additional intervention components, study design, sample size, follow-up periods, analytic approach, reported numerical outcomes, results, and limitations.
Twenty-five studies were identified. Women of a wide age range were successful at self-sampling in many African countries. More than 95% of self-samples yielded HPV DNA results. The concordance in test results between self-collected samples and clinician-collected samples was reasonably high in most studies. In all studies, the quality of cytology from self-sampling matched that of clinician-sampling. Women were generally positive about self-collection, but noted some concerns.
Self-sampling for HPV DNA testing seems to represent a feasible alternative to the Pap test. Further research is needed to provide a solid evidence base to inform using of self-sampling for HPV DNA testing for primary cervical cancer screening.
人乳头瘤病毒(HPV)检测可能适用于资源匮乏国家的宫颈癌初筛。
比较非洲地区女性自我采样和临床医生采样进行 HPV 检测的情况。
使用相关术语,从 2000 年到 2015 年,在 MEDLINE、Google Scholar、EMBASE 和几个期刊上进行了检索。
选择的研究比较了自我采样和临床医生采样的 HPV 检测。
数据提取表格包括 HPV 筛查类型的描述、任何附加干预措施的描述、研究设计、样本量、随访期、分析方法、报告的数值结果、结果和局限性。
确定了 25 项研究。在许多非洲国家,年龄范围广泛的女性都成功地进行了自我采样。超过 95%的自我采样获得了 HPV DNA 结果。在大多数研究中,自我采集样本和临床医生采集样本的检测结果具有相当高的一致性。在所有研究中,自我采样的细胞学质量与临床医生采样相当。女性对自我采样普遍持积极态度,但也提出了一些关注。
HPV DNA 检测的自我采样似乎是巴氏涂片的一种可行替代方法。需要进一步的研究为使用自我采样进行 HPV DNA 检测作为宫颈癌初筛提供坚实的证据基础。